Lipitor Study May Influence Stroke Clinical Guidelines – NEJM Editorial

Results of a study showing that Pfizer's Lipitor reduced the overall incidence of stroke in patients with a recent stroke or transient ischemic attack is likely to encourage the adoption of statin therapy into stroke treatment guidelines, according to an editorial by David Kent (Tufts-New England Medical Center) in the Aug. 10 New England Journal of Medicine